Clinical Trial Matcher

NCT06081387

The Effect of Aerobic and Resistance Training in Patients With Type 2 Diabetes on Vitamin D Treatment

Recruiting · Not Applicable · University Ramon Llull · registry updated 2025-08-06

Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.

The purpose of this study protocol is to assess the effect of concurrent aerobic and resistance training in patients with type 2 diabetes on vitamin D treatment

Inclusion

  • Adults (females or males) older than 18 years old with a diagnosis of T2D in the clinic database
  • Patients who have been taking the combination therapy of metformin + sodium-glucose transport protein 2 inhibitors (iSGLT2), as recommended by the redGDPS 2023, with stable medication for the past 6 months.
  • Diabetic patients taking prescribed VitD treatment for at least 6 months (intervention group) and diabetic patients not taking prescribed VitD (control group)
  • Patients who signed the informed consent
  • Patients capable of performing mild to moderate physical activity (to walk steadily and independently for at least 6 minutes)

Exclusion

  • Patients taking other medication different than metformin + iSGLT2 (including combinations and insulin)
  • Patients taking polyvitaminic supplementation at the inclusion for at least, 1 month before the intervention
  • Female subjects who are pregnant
  • Patients who did not sign the informed consent

Open NCT06081387 on ClinicalTrials.govAll conditions

The Effect of Aerobic and Resistance Training in Patients With Type 2 Diabetes on Vitamin D Treatment | Clinical Trial Matcher